Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Bourge

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Pharmacology|January 28, 2003
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertensionVallerie V McLaughlin, Sean P Gaine, Robyn J Barst, et al.
Circulation. Heart Failure|August 8, 2020
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval StudyDavid M Shavelle, Akshay S Desai, William T Abraham, et al.
The American Journal of Medicine|March 16, 2013
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failureRobert C Bourge, Jerome L Fleg, Gregg C Fonarow, et al.
European Journal of Heart Failure|March 16, 2017
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS)John G F Cleland, John R Teerlink, Beth A Davison, et al.
European Journal of Heart Failure|November 6, 2014
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS studyGad Cotter, Marco Metra, Beth A Davison, et al.
European Journal of Heart Failure|September 6, 2017
Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?Gad Cotter, Marco Metra, Beth A Davison, et al.
Journal of Cardiac Failure|January 10, 2015
Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS StudyMarco Metra, Gad Cotter, Jill El-Khorazaty, et al.
Journal of Cardiac Failure|January 2, 2016
Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITASGad Cotter, Beth A Davison, Olga Milo, et al.
Circulation|February 14, 2013
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES studyMarius M Hoeper, Robyn J Barst, Robert C Bourge, et al.
Pulmonary Circulation|July 4, 2017
Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus documentFranck F Rahaghi, Hassan M Alnuaimat, Rana L A Awdish, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|January 28, 2003
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertensionVallerie V McLaughlin, Sean P Gaine, Robyn J Barst, et al.
Circulation. Heart Failure|August 8, 2020
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval StudyDavid M Shavelle, Akshay S Desai, William T Abraham, et al.
The American Journal of Medicine|March 16, 2013
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failureRobert C Bourge, Jerome L Fleg, Gregg C Fonarow, et al.
European Journal of Heart Failure|March 16, 2017
Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS)John G F Cleland, John R Teerlink, Beth A Davison, et al.
European Journal of Heart Failure|November 6, 2014
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS studyGad Cotter, Marco Metra, Beth A Davison, et al.
European Journal of Heart Failure|September 6, 2017
Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?Gad Cotter, Marco Metra, Beth A Davison, et al.
Journal of Cardiac Failure|January 10, 2015
Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS StudyMarco Metra, Gad Cotter, Jill El-Khorazaty, et al.
Journal of Cardiac Failure|January 2, 2016
Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITASGad Cotter, Beth A Davison, Olga Milo, et al.
Circulation|February 14, 2013
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES studyMarius M Hoeper, Robyn J Barst, Robert C Bourge, et al.
Pulmonary Circulation|July 4, 2017
Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus documentFranck F Rahaghi, Hassan M Alnuaimat, Rana L A Awdish, et al.
Pageof 10